Farrow Jeffrey S (CIK 1405253) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-17). Recent activity: Buy TARS (27,881 shares), Sell TARS (14,396 shares), Sell TARS (2,111 shares), Sell TARS (2,133 shares), Sell TARS (2,186 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Financial Officer and Chief Strategy Officer | Buy | 27,881 | $0 |
| 2026-06-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Financial Officer and Chief Strategy Officer | Sell | 14,396 | $877,436 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Financial Officer and Chief Strategy Officer | Sell | 2,111 | $146,546 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Financial Officer and Chief Strategy Officer | Sell | 2,133 | $146,558 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Financial Officer and Chief Strategy Officer | Sell | 2,186 | $146,462 |
| 2026-03-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Financial Officer and Chief Strategy Officer | Buy | 13,042 | $0 |
| 2025-06-18 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Financial Officer and Chief Strategy Officer | Buy | 27,881 | $0 |
| 2025-06-18 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Financial Officer and Chief Strategy Officer | Sell | 13,608 | $550,035 |
来源：SEC Form 4 申报文件 · 截至 2026-06-17